Story thread · 3 reports / 2 sources
FDA Approval Marks A Turning Point For BeOne Medicines (ONC)
finance.yahoo.com · 13d
How the coverage leans
Across 2 sources · syndicated copies counted once
First report: BeOne Medicines Announces New Phase 3 Survival Data Reinforcing Benefit of ZIIHERA-Containing Regimens in First-Line HER2+ Gastroesophageal Cancer — financialpost.com, 15d
The conversation · 0
Sign in to join the conversation.
No comments yet — start the thread.